Linked below are the preliminary powerpoint presentations received to date from speakers for the June 14-15, 2001 conference on Medical Innovations in the Changing Healthcare Marketplace. Those not received prior to the conference will be collected and posted following the conference.

Mike Atkins, "Prognosis, Management and Cost of Treating Stage IV Melanoma"

Kathy Behrens, "Cardiovascular Disease - Fostering High-Value Medical Innovation"

Paul Citron, "Technology Cost Effectiveness" (large file)

David Cutler, "The Reduction of Cardiovascular Disease Mortality"

Thomas Fogarty, "Incentives and Deterents to Device Innovation"

Susan Bartlett Foote, "Fostering High-Value Medical Innovation"

Mark Hlatky, "Prevention of Sudden Cardiac Death"

Bruce Hillner, "Burden of Illness and Cost Projection Associated with Metastatic Melanoma"

Brandon Hull, "Fostering High-Value Innovation: The Venture Capital Perspective"(large file)

Alison Keith, "Understanding Increases in Pharmaceutical Costs"

Jonathan Lewis, "Melanoma - Fighting Windmills?" (large file)

Dan Mark, "No Title"

Kevin Murphy, "The Economic Value of Increased Longevity and Medical Research"

Elizabeth Nabel, "Should Cost Effective Measures Be Used to Support Reimbursement? The Case of Intravascular Ultrasound (IVUS) and Drug Releasing Stents" (large file)

Richard Padzur, "Regulatory Challenges and Initiatives"

Jamie Robinson, "Consumerism and Medical Technology"

Bruce Scharschmidt, "Metastic Melanoma: Cancer as Paradigm"

Sheila Smith, "The Macro Picture - Medical Innovation and Growth in Healthcare Costs"

Laurel Sweeney, "Innovations in the Treatment of Cardiovascular Disease: The Value of Medical Technology" (large file)

Peggy Tucker, "Trends in Melanoma: Incidence and Mortality in the United States"(large file)

Sean Tunis, "Medicare Technology Policy: Promoting Beneficial Innovation"

Robert Young, "No Title"(large file)